These include comprehensive hormone panels (DUTCH testing), advanced lipid particle analysis (NMR LipoProfile), inflammatory markers (hs-CRP, homocysteine), nutrient assessments (vitamin D, B12, magnesium, zinc), thyroid panels (TSH, free T3, free T4, reverse T3, antibodies), genetic testing (MTHFR, pharmacogenomics), and organic acids testing
F.JudgeA
The Role of Innovation in Diabetes Care Innovation is driving progress in diabetes care, offering new hope for patients and healthcare providers
The glucagon-like peptide (GLP)-1 agonists weight loss drugs market is on a robust growth trajectory, expected to expand from $15.5 billion in 2025 to $18.02 billion in 2026, at a CAGR of 16.3%